Abcam, ab140186, Anti-AIG1 antibody

Size: 100µL
Rabbit Polyclonal AIG1 antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Synthetic Peptide within Human AIG1.
Key facts
Host species:Rabbit,
Clonality:Polyclonal,
Isotype:IgG,
Carrier free:No,
Reacts with:Human,
Applications:ICC/IF, IHC-P, WBSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:Synthetic Peptide within Human AIG1. The exact immunogen used to generate this antibody is proprietary information.Q9NVV5

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Immunogen, Storage buffer-pH: 7.2Preservative: 0.02% Sodium azideConstituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage duration-1-2 weeks, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions--20°C, Aliquoting information-Upon delivery aliquot

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
AIG1 also known as Androgen-Induced Gene 1 functions mechanically as a membrane protein. The mass of AIG1 is approximately 18 kDa. This target is expressed mainly in the prostate and other androgen-responsive tissues. Its expression also occurs in various cells though at different levels.
Biological function summary
AIG1 plays a significant role in cell growth and development. It participates in cellular signaling and may involve in cellular stress responses. Although not strictly part of a known protein complex AIG1 may interact with other proteins in cellular processes that have yet to be fully characterized.
Pathways
AIG1 involvement occurs in androgen receptor signaling and possibly in stress response pathways. Interaction with these pathways suggests connections with proteins such as the androgen receptor and other signaling molecules. The function within these pathways reflects its role in modulating cellular activity in response to hormonal stimuli.
AIG1 has associations with prostate cancer and possibly benign prostatic hyperplasia. Its link to prostate cancer suggests a connection with the androgen receptor and related signaling pathways. These relations indicate that AIG1 might act in the development or progression of prostate-related conditions.